Hide Board Information

Show Board Information

Alzamend Neuro Inc. ALZN

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/21/2024 9:17:35 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 2

Alzamend Neuro Inc. (NASDAQ: ALZN) Stock Message Board

1. ALZN Company Profile

    

2. ALZN Time & Sales

    

3. ALZN Recent News

    

4. ALZN Filings

    

5. ALZN Financials

    

6. ALZN Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

5	$ALZN RHH15.06 got S@$4 and now filling gap	znewcar1	08/21/2024 9:17:35 AM
4	ALZN Hod 13.64 ALZN 529% v33,1M	znewcar1	08/19/2024 10:03:12 AM
3	$ALZN Hod13.48 RS-city! F841K	znewcar1	08/19/2024 10:02:27 AM
2	ALZN 28% v57M c3.08 f88,8M H gap up dipped a	znewcar1	12/14/2021 9:34:20 PM
1	ALZN Stock Chart Video Analysis 12-07-2021 (1)	Chasing Stars	12/07/2021 6:08:58 PM

Recent Articles

• Transformative Cancer Vaccine EVX-04 Shines at Major Meeting
• Exploring Recent Advancements in CARVYKTI and LUCAR-G39D Therapies
• Unraveling Market Disconnects: Investment Opportunities Ahead
• Shaquille O'Neal's Basketball Journey: From Reebok to Walmart
• Urgent Appeal for Ongoing Hepatitis B Vaccination in Newborns
• Copper Property CTL Trust Monthly Update for November 2025
• Elon Musk's Inspiring Advice for Aspiring Innovators
• Investigation of Major Mergers: A Look into Four Corporations
• How Chad IDE is Transforming Developer Productivity Today
• BexBack Unveils Exciting $100 Welcome Bonus for Traders
• Ray Dalio's Humble Beginnings: A Lesson in Resilience
• Lundbeck's Bexicaserin Shows Promise in Managing Childhood Epilepsies
• Lundbeck Unveils Positive Findings on Bexicaserin for Unique Epilepsies
• RadiantVibe Capital Unveils Insight Access Dashboard Initiative
• Kevin O'Leary's Formula for Financial Success: The $5M Rule
• Educators Unite for a Brighter Future at the Yidan Summit
• Elon Musk's Response to EU's $140 Million Penalty on X
• Copper Market Perspectives: Bullish Trends Amidst Contrasting Views
• Prelude Therapeutics Unveils Innovative MPN Treatment Breakthrough
• Current Trends in Cryptocurrency Markets: BTC, DOGE, ETH Updates
• Former MrBeast Creator Launches AI Platform for Content
• LiberNovo Launches Revolutionary Ergonomic Chair Globally
• LiberNovo Launches Omni Ergonomic Chair in European Market
• Blokees Unveils Exciting New Products at Major Comic Event
• Jensen Huang Reflects on Partnership with Elon Musk and Tesla
• Significant Progress in CLL Treatment with Lisaftoclax Insights
• New Findings on Lisaftoclax at ASH Annual Meeting 2025
• Marjorie Taylor Greene Opens Up About Trump and Political Rift
• Opportunity for Sprouts Farmers Market Investors Amid Legal Actions
• Labor Management Systems: A Pathway to Workforce Optimization
• Dave Ramsey Encourages Workers to Seek Fulfillment Elsewhere
• Perrigo Company Faces Class Action: Key Details for Investors
• Breakthrough CAR-T Therapy Shows Promise in Non-Hodgkin's Lymphoma
• CARVYKTI® Shows Promising Long-Term Remission Rates in Myeloma
• Exploring the Upcoming Boom in In-Memory Database Solutions
• System Infrastructure Software Market Expected to Surge by 2032
• Genmab's Epcoritamab Shows Promising Results in Trials
• Nurix Therapeutics Advances Bexobrutideg for CLL Patients
• Cogent Biosciences Unveils SUMMIT Study Insights on Bezuclastinib
• Class Action Lawsuit Filed Against Blue Owl Capital: Key Info
• Promising Phase 1 Results of Bexobrutideg for CLL Patients
• Cogent Biosciences Shares SUMMIT Trial Outcomes on Bezuclastinib
• Top 5 Trending Stocks: Insights on META, NFLX, and More
• CARVYKTI® Shows Promise in Long-Term Remission of Myeloma
• Concerns Rise Over ALT5 Sigma's Financial Stability and Audit Issues
• Education Leaders Unite for Change at Yidan Prize Summit 2025
• Projected Growth of Peptide Therapeutics Market by 2032
• Marex Stockholder Alert: Important Legal Deadline Approaching
• Comparative Analysis of MP Materials and USA Rare Earth Investment Prospects
• Viatris Sells Equity Stake in Biocon Biologics for $815 Million